Reuters logo
BRIEF-Santhera repositions omigapil in congenital muscular dystrophy
July 17, 2014 / 5:26 AM / 3 years ago

BRIEF-Santhera repositions omigapil in congenital muscular dystrophy

July 17 (Reuters) - Santhera Pharmaceuticals Holding AG : * Says repositions omigapil in congenital muscular dystrophy * Says initiates clinical development program with public-private partners * Says patient enrolment is expected to start in late 2014 * Source text for Eikon * Further company coverage

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below